LDN Social Media
Get connected with us on social networks
Ulrich Lanius, PhD and Galyn Forster, MS, LPC - Opioid Antagonists and Traumatic Brain Injury (2017 Conference) (LDN, low dose naltrexone)
They begin their presentation by discussing Naltrexone and seizure activity, as demonstrated through clinical trials. They found that later dosage adjustments were helpful in reducing the cognitive effects.
They also discuss the results of LDN and placebo trials, finding Low Dose Naltrexone (LDN) to be incredibly successful in treating autoimmune diseases such as Crohn’s and Multiple Sclerosis (MS).
This is a summary of Ulrich Lanius and Galyn Forster’s presentation. Please listen to the rest of Ulrich and Galyn’s presentation by clicking on the video above.
Past Conferences can be found https://ldnresearchtrust.org/ldn-conferences